Mark F. Kavlick
- Infectious Diseases top 1%
- Virology top 0.5%
- Molecular Biology
- Oncology top 10%
- Epidemiology
- Co-authors
- Hiroaki MitsuyaRobert YarchoanKazuhisa YoshimuraEiji KojimaT ShirasakaTakamasa UenoSudhichai ChokekijchaiBidyut Roy
- Topics
- HIV Research and Treatment (18 papers)HIV/AIDS drug development and treatment (17 papers)HIV/AIDS Research and Interventions (9 papers)
- Partner nations
- United StatesJapanGeorgia
In The Last Decade
Mark F. Kavlick
30 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 83
- Infectious Diseases 1.2k
- Virology 1.1k
- Molecular Biology 377
- Oncology 233
- Epidemiology 215
Countries citing papers authored by Mark F. Kavlick
This map shows the geographic impact of Mark F. Kavlick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark F. Kavlick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark F. Kavlick more than expected).
Fields of papers citing papers by Mark F. Kavlick
This network shows the impact of papers produced by Mark F. Kavlick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark F. Kavlick. The network helps show where Mark F. Kavlick may publish in the future.
Co-authorship network of co-authors of Mark F. Kavlick
This figure shows the co-authorship network connecting the top 25 collaborators of Mark F. Kavlick. A scholar is included among the top collaborators of Mark F. Kavlick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark F. Kavlick. Mark F. Kavlick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 10 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 19 | |
| 6 | 14 | |
| 7 | 23 | |
| 8 | 41 | |
| 9 | 42 | |
| 10 | 23 | |
| 11 | 234 | |
| 12 | 122 | |
| 13 | 6 | |
| 14 | 2 | |
| 15 | 65 | |
| 16 | 87 | |
| 17 | 61 | |
| 18 | 32 | |
| 19 | 70 | |
| 20 | 66 |
About Mark F. Kavlick
Mark F. Kavlick is a scholar working on Virology, Infectious Diseases and Genetics, having authored 30 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (18 papers), HIV/AIDS drug development and treatment (17 papers) and HIV/AIDS Research and Interventions (9 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (1.2k citations) and Pathology and Forensic Medicine (185 citations). Mark F. Kavlick has collaborated with scholars based in United States, Japan and Georgia. Frequent co-authors include Hiroaki Mitsuya, Robert Yarchoan, Kazuhisa Yoshimura, Eiji Kojima, T Shirasaka, Takamasa Ueno, Sudhichai Chokekijchai, Bidyut Roy, Wei Gao and Eddy Arnold. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.